{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T02:24:42Z","timestamp":1648607082348},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2010,8,6]],"date-time":"2010-08-06T00:00:00Z","timestamp":1281052800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Childs Nerv Syst"],"published-print":{"date-parts":[[2011,2]]},"DOI":"10.1007\/s00381-010-1255-2","type":"journal-article","created":{"date-parts":[[2010,8,5]],"date-time":"2010-08-05T11:43:56Z","timestamp":1281008636000},"page":"279-284","source":"Crossref","is-referenced-by-count":1,"title":["Retrospective analysis of the effectiveness of first-line antiepileptic drugs for generalized onset and unclassified epileptic seizures in Chinese children"],"prefix":"10.1007","volume":"27","author":[{"given":"Ying-Xue","family":"Ding","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li-Ping","family":"Zou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming-Sheng","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lu-Liang","family":"Meng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fang","family":"Fang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chang-Hong","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,8,6]]},"reference":[{"key":"1255_CR1","first-page":"1017","volume":"34","author":"SF Berkovic","year":"2005","unstructured":"Berkovic SF (2005) Treatment with anti-epileptic drugs. Aust Fam Physician 34:1017\u20131020","journal-title":"Aust Fam Physician"},{"key":"1255_CR2","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1365-2710.2006.00717.x","volume":"31","author":"IB Bondareva","year":"2006","unstructured":"Bondareva IB, Jelliffe RW, Gusev EI, Guekht AB, Melikyan EG, Belousov YB (2006) Population pharmacokinetic modelling of carbamazepine in epileptic elderly patients: implications for dosage. J Clin Pharm Ther 31:211\u2013221","journal-title":"J Clin Pharm Ther"},{"key":"1255_CR3","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0920-1211(02)00010-4","volume":"49","author":"G Coppola","year":"2002","unstructured":"Coppola G, Capovilla G, Montagnini A, Romeo A, Spano M, Tortorella G, Veggiotti P, Viri M, Pascotto A (2002) Topiramate as add-on drug in severe myoclonic epilepsy in infancy: an Italian multicenter open trial. Epilepsy Res 49:45\u201348","journal-title":"Epilepsy Res"},{"key":"1255_CR4","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1212\/01.WNL.0000123693.82339.FC","volume":"62","author":"JA French","year":"2004","unstructured":"French JA, Kanner AM, Bautista J, Abou-Khalil B, Browne T, Harden CL, Theodore WH, Bazil C, Stern J, Schachter SC, Bergen D, Hirtz D, Montouris GD, Nespeca M, Gidal B, Marks WJ Jr, Turk WR, Fischer JH, Bourgeois B, Wilner A, Faught RE Jr, Sachdeo RC, Beydoun A, Glauser TA (2004) Efficacy and tolerability of the new antiepileptic drugs I: treatment of new onset epilepsy: report of the therapeutics and technology assessment subcommittee and quality standards subcommittee of the American Academy of Neurology and the American Epilepsy Society. Neurology 62:1252\u20131260","journal-title":"Neurology"},{"key":"1255_CR5","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.seizure.2007.04.003","volume":"16","author":"T Gerstner","year":"2007","unstructured":"Gerstner T, Bauer MO, Longin E, Bell N, Koenig SA (2007) Reversible hepatotoxicity, pancreatitis, coagulation disorder and simultaneous bone marrow suppression with valproate in a 2-year-old girl. Seizure 16:554\u2013556","journal-title":"Seizure"},{"key":"1255_CR6","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.eplepsyres.2005.09.024","volume":"68","author":"FG Gilliam","year":"2006","unstructured":"Gilliam FG, Santos JM (2006) Adverse psychiatric effects of antiepileptic drugs. Epilepsy Res 68:67\u201369","journal-title":"Epilepsy Res"},{"key":"1255_CR7","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.seizure.2005.01.006","volume":"14","author":"S Grosso","year":"2005","unstructured":"Grosso S, Galimberti D, Farnetani MA, Cioni M, Mostardini R, Vivarelli R, Di Bartolo RM, Bernardoni E, Berardi R, Morgese G, Balestri P (2005) Efficacy and safety of topiramate in infants according to epilepsy syndromes. Seizure 14:183\u2013189","journal-title":"Seizure"},{"key":"1255_CR8","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.clineuro.2005.08.007","volume":"108","author":"Y Hanssens","year":"2006","unstructured":"Hanssens Y, Al-Asmi A, Al-Busaidi I, Deleu D (2006) Efficacy and tolerability of antiepileptic drugs in an Omani epileptic population. Clin Neurol Neurosurg 108:532\u2013538","journal-title":"Clin Neurol Neurosurg"},{"key":"1255_CR9","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1111\/j.1528-1167.2006.00843_5.x","volume":"47","author":"K Iinuma","year":"2006","unstructured":"Iinuma K, Morimoto K, Akiyama T, Ikeda A, Kurihara M (2006) Proposed diagnostic scheme for the classification of epileptic seizures and epilepsies (ILAE, 2001): proposal from Japan Epilepsy Society. Epilepsia 47:1588\u20131589, discussion 1590\u20131581","journal-title":"Epilepsia"},{"key":"1255_CR10","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1038\/oby.2005.161","volume":"13","author":"KM Klein","year":"2005","unstructured":"Klein KM, Hamer HM, Reis J, Schmidtke J, Oertel WH, Theisen FM, Hebebrand J, Rosenow F (2005) Weight change in monozygotic twins treated with valproate. Obes Res 13:1330\u20131334","journal-title":"Obes Res"},{"key":"1255_CR11","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1111\/j.1528-1167.2006.00846.x","volume":"47","author":"SA Koenig","year":"2006","unstructured":"Koenig SA, Buesing D, Longin E, Oehring R, Haussermann P, Kluger G, Lindmayer F, Hanusch R, Degen I, Kuhn H, Samii K, Jungck A, Bruckner R, Seitz R, Boxtermann W, Weber Y, Knapp R, Richard HH, Weidner B, Kasper JM, Haensch CA, Fitzek S, Hartmann M, Borusiak P, Muller-Deile A, Degenhardt V, Korenke GC, Hoppen T, Specht U, Gerstner T (2006) Valproic acid-induced hepatopathy: nine new fatalities in Germany from 1994 to 2003. Epilepsia 47:2027\u20132031","journal-title":"Epilepsia"},{"key":"1255_CR12","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1056\/NEJM200002033420503","volume":"342","author":"P Kwan","year":"2000","unstructured":"Kwan P, Brodie MJ (2000) Early identification of refractory epilepsy. N Engl J Med 342:314\u2013319","journal-title":"N Engl J Med"},{"key":"1255_CR13","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1046\/j.1528-1157.2001.04501.x","volume":"42","author":"P Kwan","year":"2001","unstructured":"Kwan P, Brodie MJ (2001) Effectiveness of first antiepileptic drug. Epilepsia 42:1255\u20131260","journal-title":"Epilepsia"},{"key":"1255_CR14","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.2165\/00019053-200523110-00008","volume":"23","author":"A Lloyd","year":"2005","unstructured":"Lloyd A, McIntosh E, Price M (2005) The importance of drug adverse effects compared with seizure control for people with epilepsy: a discrete choice experiment. Pharmacoeconomics 23:1167\u20131181","journal-title":"Pharmacoeconomics"},{"key":"1255_CR15","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.yebeh.2006.06.018","volume":"9","author":"MI Lossius","year":"2006","unstructured":"Lossius MI, Clench-Aas J, van Roy B, Mowinckel P, Gjerstad L (2006) Psychiatric symptoms in adolescents with epilepsy in junior high school in Norway: a population survey. Epilepsy Behav 9:286\u2013292","journal-title":"Epilepsy Behav"},{"key":"1255_CR16","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.2165\/00003495-200767150-00008","volume":"67","author":"KA Lyseng-Williamson","year":"2007","unstructured":"Lyseng-Williamson KA, Yang LP (2007) Topiramate: a review of its use in the treatment of epilepsy. Drugs 67:2231\u20132256","journal-title":"Drugs"},{"key":"1255_CR17","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/S0140-6736(07)60461-9","volume":"369","author":"AG Marson","year":"2007","unstructured":"Marson AG, Al-Kharusi AM, Alwaidh M, Appleton R, Baker GA, Chadwick DW, Cramp C, Cockerell OC, Cooper PN, Doughty J, Eaton B, Gamble C, Goulding PJ, Howell SJ, Hughes A, Jackson M, Jacoby A, Kellett M, Lawson GR, Leach JP, Nicolaides P, Roberts R, Shackley P, Shen J, Smith DF, Smith PE, Smith CT, Vanoli A, Williamson PR (2007) The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial. Lancet 369:1016\u20131026","journal-title":"Lancet"},{"key":"1255_CR18","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1212\/01.wnl.0000167193.53817.0f","volume":"65","author":"KA McVicar","year":"2005","unstructured":"McVicar KA, Ballaban-Gil K, Rapin I, Moshe SL, Shinnar S (2005) Epileptiform EEG abnormalities in children with language regression. Neurology 65:129\u2013131","journal-title":"Neurology"},{"issue":"Suppl 3","key":"1255_CR19","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/j.1528-1167.2009.02040.x","volume":"50","author":"A Neligan","year":"2009","unstructured":"Neligan A, Shorvon SD (2009) The history of status epilepticus and its treatment. Epilepsia 50(Suppl 3):56\u201368","journal-title":"Epilepsia"},{"key":"1255_CR20","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1212\/01.wnl.0000286959.22040.6e","volume":"70","author":"Y Schiller","year":"2008","unstructured":"Schiller Y, Najjar Y (2008) Quantifying the response to antiepileptic drugs: effect of past treatment history. Neurology 70:54\u201365","journal-title":"Neurology"},{"key":"1255_CR21","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/j.2042-7158.2004.tb02607.x","volume":"56","author":"MK Trojnar","year":"2004","unstructured":"Trojnar MK, Wierzchowska-Cioch E, Krzyzanowski M, Jargiello M, Czuczwar SJ (2004) New generation of valproic acid. Pol J Pharmacol 56:283\u2013288","journal-title":"Pol J Pharmacol"},{"key":"1255_CR22","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/S1474-4422(02)00160-6","volume":"1","author":"R Tuchman","year":"2002","unstructured":"Tuchman R, Rapin I (2002) Epilepsy in autism. Lancet Neurol 1:352\u2013358","journal-title":"Lancet Neurol"},{"key":"1255_CR23","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1745-6215-8-34","volume":"8","author":"C Tudur Smith","year":"2007","unstructured":"Tudur Smith C, Marson AG, Chadwick DW, Williamson PR (2007) Multiple treatment comparisons in epilepsy monotherapy trials. Trials 8:34","journal-title":"Trials"},{"key":"1255_CR24","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/j.1528-1167.2006.00387.x","volume":"47","author":"A Velez","year":"2006","unstructured":"Velez A, Eslava-Cobos J (2006) Epilepsy in Colombia: epidemiologic profile and classification of epileptic seizures and syndromes. Epilepsia 47:193\u2013201","journal-title":"Epilepsia"},{"key":"1255_CR25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta9150","volume":"9","author":"J Wilby","year":"2005","unstructured":"Wilby J, Kainth A, Hawkins N, Epstein D, McIntosh H, McDaid C, Mason A, Golder S, O'Meara S, Sculpher M, Drummond M, Forbes C (2005) Clinical effectiveness, tolerability and cost-effectiveness of newer drugs for epilepsy in adults: a systematic review and economic evaluation. Health Technol Assess 9:1\u2013157, iii\u2013iv","journal-title":"Health Technol Assess"}],"container-title":["Child's Nervous System"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00381-010-1255-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00381-010-1255-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00381-010-1255-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T15:31:20Z","timestamp":1559057480000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00381-010-1255-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8,6]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,2]]}},"alternative-id":["1255"],"URL":"https:\/\/doi.org\/10.1007\/s00381-010-1255-2","relation":{},"ISSN":["0256-7040","1433-0350"],"issn-type":[{"value":"0256-7040","type":"print"},{"value":"1433-0350","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,8,6]]}}}